280 related articles for article (PubMed ID: 28781151)
1. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan.
Ko BS; Chen WT; Kung HC; Wu UI; Tang JL; Yao M; Chen YC; Tien HF; Chang SC; Chuang YC; Lin DT; ; ; ; ; ;
J Microbiol Immunol Infect; 2018 Jun; 51(3):287-301. PubMed ID: 28781151
[TBL] [Abstract][Full Text] [Related]
2. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
Kung HC; Huang PY; Chen WT; Ko BS; Chen YC; Chang SC; Chuang YC; ; ; ;
J Microbiol Immunol Infect; 2018 Feb; 51(1):1-17. PubMed ID: 28781150
[TBL] [Abstract][Full Text] [Related]
3. Recommendations and guidelines for the treatment of pneumonia in Taiwan.
Chou CC; Shen CF; Chen SJ; Chen HM; Wang YC; Chang WS; Chang YT; Chen WY; Huang CY; Kuo CC; Li MC; Lin JF; Lin SP; Ting SW; Weng TC; Wu PS; Wu UI; Lin PC; Lee SS; Chen YS; Liu YC; Chuang YC; Yu CJ; Huang LM; Lin MC; ; ; ; ; ;
J Microbiol Immunol Infect; 2019 Feb; 52(1):172-199. PubMed ID: 30612923
[TBL] [Abstract][Full Text] [Related]
4. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S
Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989
[TBL] [Abstract][Full Text] [Related]
5. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
Lortholary O; Fernández-Ruiz M; Perfect JR
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
[TBL] [Abstract][Full Text] [Related]
6. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
[TBL] [Abstract][Full Text] [Related]
7. [Invasive fungal infection management in patients with hematological malignancies].
Kanda Y
Rinsho Ketsueki; 2022; 63(9):1270-1278. PubMed ID: 36198553
[TBL] [Abstract][Full Text] [Related]
8. Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients.
Lehrnbecher T; Fisher BT; Phillips B; Beauchemin M; Carlesse F; Castagnola E; Duong N; Dupuis LL; Fioravantti V; Groll AH; Haeusler GM; Roilides E; Science M; Steinbach WJ; Tissing W; Warris A; Patel P; Robinson PD; Sung L
J Clin Oncol; 2020 Sep; 38(27):3205-3216. PubMed ID: 32459599
[TBL] [Abstract][Full Text] [Related]
9. The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.
Pagano L; Caira M; Nosari A; Cattaneo C; Fanci R; Bonini A; Vianelli N; Garzia MG; Mancinelli M; Tosti ME; Tumbarello M; Viale P; Aversa F; Rossi G;
Haematologica; 2011 Sep; 96(9):1366-70. PubMed ID: 21565903
[TBL] [Abstract][Full Text] [Related]
10. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
[TBL] [Abstract][Full Text] [Related]
11. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.
Science M; Robinson PD; MacDonald T; Rassekh SR; Dupuis LL; Sung L
Pediatr Blood Cancer; 2014 Mar; 61(3):393-400. PubMed ID: 24424789
[TBL] [Abstract][Full Text] [Related]
12. A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne.
Girmenia C; Aversa F; Busca A; Candoni A; Cesaro S; Luppi M; Pagano L; Rossi G; Venditti A; Nosari AM; ; ; ; ;
Hematol Oncol; 2013 Sep; 31(3):117-26. PubMed ID: 23037867
[TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
[TBL] [Abstract][Full Text] [Related]
14. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.
Gamaletsou MN; Walsh TJ; Sipsas NV
Turk J Haematol; 2018 Mar; 35(1):1-11. PubMed ID: 29391334
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO).
Ruhnke M; Behre G; Buchheidt D; Christopeit M; Hamprecht A; Heinz W; Heussel CP; Horger M; Kurzai O; Karthaus M; Löffler J; Maschmeyer G; Penack O; Rieger C; Rickerts V; Ritter J; Schmidt-Hieber M; Schuelper N; Schwartz S; Ullmann A; Vehreschild JJ; von Lilienfeld-Toal M; Weber T; Wolf HH
Mycoses; 2018 Nov; 61(11):796-813. PubMed ID: 30098069
[TBL] [Abstract][Full Text] [Related]
17. Defining standards of CARE for invasive fungal diseases in adult haematology patients: antifungal prophylaxis versus treatment.
Barnes R; Rogers T; Maertens J
J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii21-ii26. PubMed ID: 31222310
[TBL] [Abstract][Full Text] [Related]
18. [Cross-sectional investigation of first-choice of antifungal agents in empirical and preemptive antifungal therapy for patients with hematological malignancies].
Ji Y; Xu LP; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):473-7. PubMed ID: 23827099
[TBL] [Abstract][Full Text] [Related]
19. Complications of hematopoietic stem transplantation: Fungal infections.
Omrani AS; Almaghrabi RS
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):239-244. PubMed ID: 28636889
[TBL] [Abstract][Full Text] [Related]
20. Approach to diagnostic evaluation and prevention of invasive fungal disease in patients prior to allogeneic hematopoietic stem cell transplant.
O'Keeffe JC; Singh N; Slavin MA
Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14197. PubMed ID: 37988269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
